Medtech Insight

AdvaMed Doubled Its Lobbying Spending Over Past Year

Having won repeal of the device tax in late 2019, the group now focuses on CARES Act, user-fee funding

27 May 2020

• By Sue Darcey

Medtech industry trade group AdvaMed spent more than $2m to help shape US congressional bills in the first quarter of 2020 – more than double what it spent to influence the course of legislation in the first quarter of 2019. Check out our in-depth analysis here.

collage with US capitol Building and American dollars on blurred background

Medical device industry trade group AdvaMed spent $2.1m on lobbying the US Congress in the first quarter of 2020, more than twice what it spent – $1m – in the first quarter of 2019.

Overall, AdvaMed paid out $5.6m for US lobbying activities throughout 2019, according to a compilation of lobbying reports required to...